ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's disease.

Giuseppe Pepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.